Melanoma Gene Variations in Slovenian Families
Author Information
Author(s): Barbara Peric, Petra Cerkovnik, Srdjan Novakovic, Janez Zgajnar, Nikola Besic, Marko Hocevar
Primary Institution: Institute of Oncology Ljubljana
Hypothesis
To determine the prevalence of germline CDKN2A mutations and variants in members of families with familial cutaneous melanoma and in patients with multiple primary cutaneous melanoma.
Conclusion
The study found a high prevalence of CDKN2A mutations in Slovenian familial melanoma patients and no CDK4 mutations.
Supporting Evidence
- Seven families with CDKN2A mutations were discovered, indicating a significant genetic predisposition.
- The study identified a novel mutation (L94Q) not previously reported in other populations.
- The frequency of certain MC1R gene variants was slightly higher in melanoma patients compared to controls.
Takeaway
This study looked at families with melanoma and found that many had a specific gene mutation that increases their risk of the disease.
Methodology
The study included genetic testing of 64 individuals from melanoma families and a control group to identify mutations and variants in melanoma susceptibility genes.
Potential Biases
Potential bias in participant selection as families were referred for genetic counseling.
Limitations
The study may not represent the entire Slovenian population due to the specific selection of families with melanoma.
Participant Demographics
The study included 28 patients, 7 healthy relatives, and 54 healthy controls, with a mix of genders and ages.
Statistical Information
P-Value
0.257
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website